comparemela.com

Latest Breaking News On - Medicine mindmed company profile - Page 7 : comparemela.com

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) Given Consensus Recommendation of Buy by Analysts

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus rating of “Buy” from the eight ratings firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have issued ratings on the stock […]

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) Stock Position Lowered by AdvisorShares Investments LLC

AdvisorShares Investments LLC reduced its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 17.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,310 shares of the company’s stock after selling 20,127 shares during the […]

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) Receives Average Rating of Buy from Analysts

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight research firms that are covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last […]

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) Shares Bought by North Star Investment Management Corp

North Star Investment Management Corp. grew its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 27,551.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,125 shares of the company’s stock after buying an additional 9,092 shares during […]

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) Given Consensus Rating of Buy by Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) has been assigned an average recommendation of “Buy” from the eight brokerages that are covering the company, Marketbeat reports. Eight analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock in the last year […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.